Product fact sheet
BON CHARGE Max Red Light Therapy Device: Technical Specifications
Source-backed BON CHARGE Max panel facts covering size, wavelengths, LED count, beam angle, published power and current measurement gaps.
A larger two-wavelength mains-powered BON CHARGE panel with manufacturer-published dimensions, LED count and power, plus a current manual index; independent output measurements are not normalized in the current record.
larger two-wavelength manufacturer-spec comparisons, buyers comparing simple panel architectures
buyers requiring accredited third-party radiometric data, comparisons that treat manufacturer irradiance claims as equivalent to LightLab measurements
Key tradeoff: Primary product documentation is detailed enough for physical and electrical facts, but optical-output comparability remains limited by missing independent method detail.
This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.
The BON CHARGE Max is a larger mains-powered two-wavelength panel. Its current manufacturer record publishes physical dimensions, LED count, wavelength pair, beam angle and electrical power.
Published hardware profile
The normalized record uses the manufacturer’s current values for 660 nm / 850 nm, 200 LEDs, a 30° beam angle, approximately 91 × 21 × 6.5 cm dimensions, and 1000 W published power.
These are manufacturer-published specifications. They are not relabeled as independent measurements.
Why the irradiance claim is not normalized beside LightLab data
BON CHARGE publishes an irradiance figure for this panel, but the current source material available to Homeapotherapy does not establish the same calibrated spectral band, instrument, spatial averaging and geometry used by the LightLab records elsewhere in the catalog. Showing those values in one normalized field would imply comparability the source record does not support.
What the current record does not establish
Homeapotherapy does not yet have an independent common-protocol radiometric report for this model and has not performed hands-on electrical, optical, acoustic or thermal testing.
See Red Light Device Specifications Explained for the evidence and comparison rules used across the catalog.
Technical specifications
Published specs and what they mean
Physical
- Dimensions
- 91 × 21 × 6.5 cm (35.8 × 8.37 × 2.56 in) Basis: Manufacturer published Current manufacturer comparison table. Source: Max Red Light Therapy Device
Optical
- Published wavelengths
- 660 / 850 nm Basis: Manufacturer published Current manufacturer comparison table. Source: Max Red Light Therapy Device
- LED count
- 200 LEDs Basis: Manufacturer published Current manufacturer comparison table. Source: Max Red Light Therapy Device
- Beam angle
- 30° Basis: Manufacturer published Manufacturer specification family uses a 30-degree beam angle. Source: Max Red Light Therapy Device
Electrical
- Published power
- 1000 W Basis: Manufacturer published Manufacturer product comparison value; not independently measured wall draw. Source: Max Red Light Therapy Device
What the current record does not establish
- No independent common-protocol irradiance report is normalized.
- Manufacturer-published irradiance is intentionally not inserted into LightLab-style irradiance keys.
- No Homeapotherapy hands-on measurements exist.
A missing field is not evidence that the device lacks the feature or performs poorly. It means we do not currently have a sufficiently comparable, sourced value in the normalized record.
Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.
Dose and irradiance context
What the output number means over time
Fluence is a calculation, not a treatment recommendation. For continuous output, fluence in J/cm² equals irradiance in mW/cm² × seconds ÷ 1000. The calculation only remains meaningful at the measurement conditions used for the irradiance value.
No comparable independent average irradiance is normalized
This device may have a manufacturer-published irradiance claim, but Homeapotherapy does not calculate time-to-fluence from that number unless the current record contains a sufficiently defined independent area-average measurement. This avoids presenting unlike measurement methods as interchangeable.
What this calculation still cannot tell you
- whether this is an effective dose for any condition;
- how irradiance changes at a different distance or across curved anatomy;
- how much energy reaches tissue below the surface;
- whether a study used the same wavelength distribution, spot size, pulse mode or treatment schedule;
- whether peak irradiance would produce the same area exposure as the average value shown here.
Read Red Light Irradiance, Fluence and Dose Explained before trying to compare this output with a clinical paper or another panel.
Clinical evidence context
Where these wavelengths overlap with human research
Published device wavelengths: 660 / 850 nm.
This is a hardware-to-literature cross-reference, not a claim that this product treats any condition. A matching nominal wavelength does not reproduce a study's irradiance, dose, distance, treatment area, emitter geometry, schedule or patient population.
Research areas worth checking
- Pattern hair loss — human studies commonly use visible-red wavelengths, especially around the mid-600 nm range.
- Acne and inflammatory skin — red-light protocols exist, but acne studies may also use blue light and should not be generalized from panel specs.
- Skin rejuvenation and photoaging — visible-red and red/NIR LED protocols have been studied with varied devices and endpoints.
- Knee osteoarthritis — near-infrared wavelengths appear in the clinical literature, but wavelength alone does not establish an equivalent treatment protocol.
- Muscle recovery and musculoskeletal pain — research spans red and near-infrared bands with substantial protocol variation.
- Transcranial PBM and cognition — some research uses near-infrared wavelengths, but a body panel is not automatically equivalent to a head-targeted transcranial device.
- See the full wavelength-by-condition evidence chart for evidence strength, treatment geometry and major caveats.
Do not infer from wavelength overlap
- that this device is clinically proven for the linked condition;
- that more wavelengths are better;
- that the highest published irradiance is the best dose;
- that an open wound should be treated with a consumer device without appropriate wound assessment.
For wounds specifically, start with the wound-care safety decision guide before interpreting any device specification.
Safety first
What should make you slow down?
Use the product as directed, avoid treating concentrated wellness products as automatically harmless, and ask a qualified clinician when your situation or medication use makes the decision less routine.
Where to buy
Current tracked merchants
Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.
No merchant destination is currently tracked for this product.
Source trail
Primary documents and supporting evidence
- Max Red Light Therapy DeviceBON CHARGE · Manufacturer · retrieved 2026-08-11
- BON CHARGE Product User ManualsBON CHARGE · Manufacturer manual · Manual index · retrieved 2026-08-11